Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Prospective investigation of nasal mupirocin, hexachlorophene body wash, and systemic antibiotics for prevention of recurrent community-associated methicillin-resistant Staphylococcus aureus infections.

Miller LG, Tan J, Eells SJ, Benitez E, Radner AB.

Antimicrob Agents Chemother. 2012 Feb;56(2):1084-6. doi: 10.1128/AAC.01608-10. Epub 2011 Nov 14.

2.

Agents for the decolonization of methicillin-resistant Staphylococcus aureus.

McConeghy KW, Mikolich DJ, LaPlante KL.

Pharmacotherapy. 2009 Mar;29(3):263-80. doi: 10.1592/phco.29.3.263. Review.

PMID:
19249946
3.

In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice.

Guo Y, Ramos RI, Cho JS, Donegan NP, Cheung AL, Miller LS.

Antimicrob Agents Chemother. 2013 Feb;57(2):855-63. doi: 10.1128/AAC.01003-12. Epub 2012 Dec 3.

4.

Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial.

Ellis MW, Griffith ME, Dooley DP, McLean JC, Jorgensen JH, Patterson JE, Davis KA, Hawley JS, Regules JA, Rivard RG, Gray PJ, Ceremuga JM, Dejoseph MA, Hospenthal DR.

Antimicrob Agents Chemother. 2007 Oct;51(10):3591-8. Epub 2007 Aug 6.

5.

Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk.

Robicsek A, Beaumont JL, Thomson RB Jr, Govindarajan G, Peterson LR.

Infect Control Hosp Epidemiol. 2009 Jul;30(7):623-32. doi: 10.1086/597550.

PMID:
19496730
6.

Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections.

Fritz SA, Hogan PG, Camins BC, Ainsworth AJ, Patrick C, Martin MS, Krauss MJ, Rodriguez M, Burnham CA.

Antimicrob Agents Chemother. 2013 Jan;57(1):559-68. doi: 10.1128/AAC.01633-12. Epub 2012 Nov 12.

7.

Effect of intranasal mupirocin and chlorhexidine body wash on decolonization of community-associated methicillin-resistant Staphylococcus aureus.

Leung YH, Wong MM, Chuang SK.

Infect Control Hosp Epidemiol. 2011 Oct;32(10):1048-50. doi: 10.1086/662019. No abstract available.

PMID:
21931262
8.

First outbreak of community-acquired MRSA USA300 in France: failure to suppress prolonged MRSA carriage despite decontamination procedures.

Baud O, Giron S, Aumeran C, Mouly D, Bardon G, Besson M, Delmas J, Coignard B, Tristan A, Vandenesch F, Illes G, Lesens O.

Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1757-62. doi: 10.1007/s10096-014-2127-6. Epub 2014 May 11.

PMID:
24816900
9.

Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection.

Davis SL, Perri MB, Donabedian SM, Manierski C, Singh A, Vager D, Haque NZ, Speirs K, Muder RR, Robinson-Dunn B, Hayden MK, Zervos MJ.

J Clin Microbiol. 2007 Jun;45(6):1705-11. Epub 2007 Mar 28.

10.

Community-acquired methicillin-resistant staphylococcus aureus skin infection.

Constantinescu M, English JE.

J Pediatr Adolesc Gynecol. 2011 Aug;24(4):231-2. No abstract available.

PMID:
21861299
11.

Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations.

Solares CA, Batra PS, Hall GS, Citardi MJ.

Am J Otolaryngol. 2006 May-Jun;27(3):161-5.

PMID:
16647979
12.

Mupirocin/chlorexidine to prevent methicillin-resistant Staphylococcus aureus infections: post hoc analysis of a placebo-controlled, randomized trial using mupirocin/chlorhexidine and polymyxin/tobramycin for the prevention of acquired infections in intubated patients.

Camus C, Sebille V, Legras A, Garo B, Renault A, Le Corre P, Donnio PY, Gacouin A, Perrotin D, Le Tulzo Y, Bellissant E.

Infection. 2014 Jun;42(3):493-502. doi: 10.1007/s15010-013-0581-1. Epub 2014 Jan 25.

13.

The persistence of Staphylococcus aureus decolonization after mupirocin and topical chlorhexidine: implications for patients requiring multiple or delayed procedures.

Immerman I, Ramos NL, Katz GM, Hutzler LH, Phillips MS, Bosco JA 3rd.

J Arthroplasty. 2012 Jun;27(6):870-6. doi: 10.1016/j.arth.2012.01.010. Epub 2012 Mar 6.

PMID:
22397861
15.

Recurrent MRSA skin infections in atopic dermatitis.

Ong PY.

J Allergy Clin Immunol Pract. 2014 Jul-Aug;2(4):396-9. doi: 10.1016/j.jaip.2014.04.007. Epub 2014 May 23. Review.

PMID:
25017526
16.
17.
18.

[Antibiotic susceptibility of Staphylococcus aureus strains responsible for community-acquired skin infections].

Bernard P, Jarlier V, Santerre-Henriksen A.

Ann Dermatol Venereol. 2008 Jan;135(1):13-9. doi: 10.1016/j.annder.2007.06.004. Epub 2008 Jan 22. French.

PMID:
18342068
19.

Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline.

Ammerlaan HS, Kluytmans JA, Berkhout H, Buiting A, de Brauwer EI, van den Broek PJ, van Gelderen P, Leenders SA, Ott A, Richter C, Spanjaard L, Spijkerman IJ, van Tiel FH, Voorn GP, Wulf MW, van Zeijl J, Troelstra A, Bonten MJ; MRSA Eradication Study Group..

J Antimicrob Chemother. 2011 Oct;66(10):2409-17. doi: 10.1093/jac/dkr243. Epub 2011 Jun 30.

PMID:
21719473
20.

Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus.

Pallin DJ, Egan DJ, Pelletier AJ, Espinola JA, Hooper DC, Camargo CA Jr.

Ann Emerg Med. 2008 Mar;51(3):291-8. doi: 10.1016/j.annemergmed.2007.12.004. Epub 2008 Jan 28.

PMID:
18222564

Supplemental Content

Support Center